CD44 and prostate cancer: In particular, we focused on PC3 cells, which are derived from bone metastasis of prostate cancer and show characteristics of small cell neuroendocrine carcinoma (e.g., expressing markers such as chromogranin A, neuron-specific enolase, and the stem cell-associated marker CD44)21.